Federal Supply Schedule 36F79722D0197

Award Date 8/15/22
Last Date to Order 8/14/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded a $17.5M Blanket Purchase Agreement (BPA) to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, for the procurement of the radiopharmaceutical product Illuccix through August 2025. Illuccix is used for prostate cancer imaging and will be supplied to VA medical facilities across the country under this contract. Additionally, the VA has issued a $1.815M firm fixed price BPA call order to Telix Pharmaceuticals for the delivery...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) contract to Telix Pharmaceuticals US Inc. for the provision of various radiopharmaceuticals. The single-award BPA has a ceiling value of $4,498,000.00 and a period of performance from October 1, 2023 through September 30, 2028. Under this BPA, the VA VHA has issued a $910,000.00 firm fixed price BPA Call Order to Telix Pharmaceuticals US Inc. for the base period from...
This Federal Supply Schedule (FSS) contract award to Lantheus Medical Imaging, Inc., a manufacturer of diagnostic medical imaging agents and products, aims to provide the federal government with a diverse range of radiopharmaceuticals, nuclear medicine supplies, and specialized medical imaging technologies. The $43.2 million ceiling value contract is primarily issued against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and supports medical imaging procedures and healthcare programs...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The $7.5 million single-award BPA, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), covers the delivery of PLUVICTO and LUTATHERA, which are radiopharmaceutical products used for cancer treatment and diagnostic imaging. The VA has awarded Advanced Accelerator...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Trillamed LLC for positron emission tomography radiopharmaceuticals. The single award contract has a potential value of $1.5 million and period of performance through September 2027. Task orders issued to date include $212,629 firm fixed price delivery orders for fiscal years 2023 and 2024 for supply of radiopharmaceuticals from Trillamed's Bingham...
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 9, has awarded a single-award Blanket Purchase Agreement (BPA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The BPA has a ceiling value of $49,212,356.34 and a period of performance from December 2024 to November 2029, with five ordering periods. The BPA is for the manufacture and delivery of Pluvicto (lutetium Lu 177...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract with Medi-Physics, Inc., a subsidiary of General Electric Company, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The contract, valued at $1,100,000, facilitates the procurement of specialized radiopharmaceuticals and medical isotopes used in nuclear medicine diagnostic imaging procedures, such as positron emission tomography (PET) scans and single-photon emission computed tomography (SPECT)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a blanket purchase agreement to Trillamed LLC for the delivery of radiopharmaceuticals sodium fluoride F18 and fludeoxyglucose F18. The firm fixed price BPA call has a value of $130,041.45 and performance period through December 31, 2021. The award was made off GSA Schedule Pharmaceuticals and Drugs to provide these medical isotopes and related supplies in direct support of...
This is a $2,616,322.00 Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA), specifically through Veterans Integrated Service Network (VISN) 9, to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico). The contract is for the delivery of PYLARIFY F-18 piflufolastat, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine services and imaging programs for veterans. The contract has a 5-year performance...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VHA VISN 12) awarded a $36,471.50 firm fixed price delivery order to Blue Earth Diagnostics Inc. for the purchase of POSLUMA (FLOTUFOLASTAT F 18), a radiopharmaceutical used in positron emission tomography imaging procedures to aid in the diagnosis of prostate cancer. The delivery order was awarded off an existing indefinite-delivery/indefinite-quantity Federal Supply Schedule contract...
  • 36F79722D0197
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements
  • 10
    Federal Contract Awards

The U.S. Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, to provide radiopharmaceutical products for nuclear medicine and medical imaging services. The $225,000 multiple-award contract has an ultimate completion date of August 2027 and falls under FSS 65 I B for drugs, pharmaceuticals, and related products.

Under this FSS contract, the VA has issued several firm fixed-price delivery orders to Telix Pharmaceuticals for the supply of radiopharmaceuticals such as Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures. The delivery orders range from $165,000 to $479,500 and have ultimate completion dates through 2025. Additionally, the VA has awarded Telix Pharmaceuticals two Blanket Purchase Agreements (BPAs) valued at $17.5 million and $4.5 million to facilitate the procurement of Illuccix and other radiopharmaceuticals through 2028. These contract vehicles allow the VA to efficiently acquire Telix's products to support its healthcare system serving veterans across the country.

Generated 1/3/25, 9:07 AM